Daniela Pietra
7PUBLICATIONS
64CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|May 22, 2025
Type 2 calreticulin mutations activate ATF6 to promote BCL-xL-mediated survival in myeloproliferative neoplasms.Nicole S Arellano, William L Heaton, Mirielle C Nauman
|Nov 10, 2022
Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms.Christian Pecquet, Nicolas Papadopoulos, Thomas Balligand
|Apr 11, 2022
Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms.Juan Ibarra, Yassmin A Elbanna, Katarzyna Kurylowicz
|Dec 22, 2020
Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2P95-mutated neoplasms.Gabriele Todisco, Maria Creignou, Anna Gallì
|Jun 01, 2017
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis.F Passamonti, T Giorgino, B Mora
Pageof 2
Frequent Collaborators
6 joint publications
Elisa Rumi
4 joint publications
Ilaria Casetti
2 joint publications
Shannon E Elf
2 joint publications
Paola Guglielmelli
2 joint publications
Nicole S Arellano
2 joint publications
Oscar Borsani
2 joint publications
Michele Ciboddo
2 joint publications
Silvia Catricalà
2 joint publications
Luca Malcovati
2 joint publications
Mario Cazzola
